Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer

Journal of Urology- Netherlands

doi 10.1016/j.juro.2018.02.1652

Full Text

Abstract

Available in

Date

April 1, 2018

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology

Oncology

2013

English

Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer

Japanese Journal of Urology

Urology

2016

English

A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer

PLoS ONE

Multidisciplinary

2018

English

Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer

Journal of Urology

Urology

2018

English

Mp52-19 Impact of Enzalutamide on Pain and Health-Related Quality of Life in Men With Non-Metastatic Castration-Resistant Prostate Cancer: Prosper Study Results

Journal of Urology

Urology

2018

English

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie

Oncology

2016

English

A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer

International Journal of Clinical Oncology

English

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Plasma Levels of Enzalutamide and Its Main Metabolites in a Metastatic Castration-Resistant Prostate Cancer Patient Undergoing Hemodialysis

Clinical Genitourinary Cancer

Oncology

Urology

2019

English

Amanote Research

Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer

Journal of Urology- Netherlands

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer

A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer

Mp52-19 Impact of Enzalutamide on Pain and Health-Related Quality of Life in Men With Non-Metastatic Castration-Resistant Prostate Cancer: Prosper Study Results

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Plasma Levels of Enzalutamide and Its Main Metabolites in a Metastatic Castration-Resistant Prostate Cancer Patient Undergoing Hemodialysis